Table of Content

Executive Summary

Chapter 1 – Introduction

Chapter 2 – Trends in Big Pharma dealmaking

2.1. Introduction
2.2. Big Pharma partnering over the years
2.3. Most active Big Pharma dealmakers
2.4. Big Pharma partnering by deal type
2.5. Big Pharma partnering by therapy area
2.6. Big Pharma partnering by technology type
2.7. Deal terms for Big Pharma partnering
2.7.1 Big Pharma partnering headline values
2.7.2 Big Pharma deal upfront payments
2.7.3 Big Pharma deal milestone payments
2.7.4 Big Pharma royalty rates

Chapter 3 – Leading Big Pharma deals

3.1. Introduction
3.2. Top Big Pharma deals by value

Chapter 4 – Most active Big Pharma dealmakers

4.1. Introduction
4.2. Most active Big Pharma dealmakers
4.3. Most active Big Pharma partnering company profiles
Including Pfizer, Sanofi, Abbott, GlaxoSmithKline, Johnson & Johnson and many others

Chapter 5 – Big Pharma contracts dealmaking directory

5.1. Introduction
5.2. Big Pharma contracts dealmaking directory

Chapter 6 – Big Pharma dealmaking by technology type

Appendices

Appendix 1 – Big Pharma deals by company A-Z
Appendix 2 – Big Pharma deals by stage of development
Appendix 3 – Big Pharma deals by deal type
Appendix 4 – Big Pharma deals by therapy area
Appendix 5 – Deal type definitions
Appendix 6 – Further reading

About Wildwood Ventures

Current Partnering
Current Agreements
Recent report titles from Current Partnering

Table of figures

Figure 1: Big Pharma partnering since 2016
Figure 2: Active Big Pharma dealmaking activity– 2016 to 2023
Figure 3: Big Pharma partnering by deal type since 2016
Figure 4: Big Pharma partnering by disease type since 2016
Figure 5: Big Pharma partnering by technology type since 2016
Figure 6: Big Pharma deals with a headline value
Figure 7: Big Pharma deals with an upfront value
Figure 8: Big Pharma deals with a milestone value
Figure 9: Big Pharma deals with a royalty rate value
Figure 10: Top Big Pharma deals by value since 2016
Figure 11: Most active Big Pharma dealmakers 2016 to 2023